Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 safety trial evaluating intravenous infusion of cultured allogeneic umbilical cord-derived mesenchymal stem cells for diabetes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Umbilical cord-derived mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine | Conditions: Diabetes | Phase 1 | Status: TERMINATED